ES416383A1 - Pharmacejtical preparations - Google Patents

Pharmacejtical preparations

Info

Publication number
ES416383A1
ES416383A1 ES416383A ES416383A ES416383A1 ES 416383 A1 ES416383 A1 ES 416383A1 ES 416383 A ES416383 A ES 416383A ES 416383 A ES416383 A ES 416383A ES 416383 A1 ES416383 A1 ES 416383A1
Authority
ES
Spain
Prior art keywords
pharmacejtical
preparations
trihydroxybenzyl
seryl
hydrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES416383A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES416383A1 publication Critical patent/ES416383A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for preparing a pharmaceutical composition active against depressions and insomnia, characterized by combining l-5-hydroxytryptophan, or a pharmaceutically acceptable salt thereof, with n 1 - (d, l-seryl) -N- (2,3, 4-trihydroxybenzyl) -hydrazine, or a pharmaceutically acceptable salt thereof, in proportions corresponding to a weight ratio of about 1: 5 to about 2: 1 between l-5-hydroxy-tryptophan and n1- (d, l-seryl) -n2- (2,3,4-trihydroxybenzyl) -hydrazine. (Machine-translation by Google Translate, not legally binding)
ES416383A 1972-06-30 1973-06-28 Pharmacejtical preparations Expired ES416383A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH984672 1972-06-30

Publications (1)

Publication Number Publication Date
ES416383A1 true ES416383A1 (en) 1976-02-16

Family

ID=4356299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES416383A Expired ES416383A1 (en) 1972-06-30 1973-06-28 Pharmacejtical preparations

Country Status (18)

Country Link
AT (1) AT338412B (en)
AU (1) AU476456B2 (en)
BE (1) BE801645A (en)
CA (1) CA1015272A (en)
DD (1) DD107592A5 (en)
DE (1) DE2327636A1 (en)
ES (1) ES416383A1 (en)
FR (1) FR2190453B1 (en)
GB (1) GB1369189A (en)
HU (1) HU167292B (en)
IE (1) IE37833B1 (en)
IL (1) IL42317A (en)
LU (1) LU67898A1 (en)
NL (1) NL7308435A (en)
PH (1) PH9584A (en)
SE (1) SE407744B (en)
SU (1) SU533323A3 (en)
ZA (1) ZA733284B (en)

Also Published As

Publication number Publication date
IE37833L (en) 1973-12-30
GB1369189A (en) 1974-10-02
NL7308435A (en) 1974-01-02
IL42317A0 (en) 1973-07-30
AT338412B (en) 1977-08-25
IL42317A (en) 1976-04-30
AU5589773A (en) 1974-11-21
FR2190453A1 (en) 1974-02-01
HU167292B (en) 1975-09-27
DD107592A5 (en) 1974-08-12
DE2327636A1 (en) 1974-01-17
LU67898A1 (en) 1975-04-11
PH9584A (en) 1976-01-19
AU476456B2 (en) 1976-09-23
FR2190453B1 (en) 1976-04-09
ATA574273A (en) 1976-12-15
SU533323A3 (en) 1976-10-25
SE407744B (en) 1979-04-23
BE801645A (en) 1974-01-02
CA1015272A (en) 1977-08-09
IE37833B1 (en) 1977-10-26
ZA733284B (en) 1974-03-27

Similar Documents

Publication Publication Date Title
ES463877A1 (en) Analgesic n-(2-aminocycloaliphatic)benzamides
ES434829A1 (en) 1-{8 3-(Naphth-1-yloxy)-2-hydroxypropvl{9 -piperazine compounds and therapeutic compositions
FI51190C (en) Process for the preparation of therapeutically active, in particular N- (3,4,5-trimethoxy-cinnamoyl) -piperazine derivatives of the coronadilator.
ZA711189B (en) 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2)derivatives,process for their preparation and their use as herbicidal agents
HU170778B (en) Fungicide compositions, and process for producing l-propyl-imidazole derivatives and salts thereof as active agents
ES382842A1 (en) Aryl-substituted piperazinyl-alkylamino-uracils, -uracil ethers and -uracil thioethers and method for their production
GB1390803A (en) Medicinal tampons and compositions containing lactulose
IL42781A (en) Derivatives of(4'-(3"-indolyl)piperidino)alkylarylketones,process for preparing them and pharmaceutical compositions containing same
ES369624A1 (en) Alkanolamine derivatives
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
ES410825A1 (en) Quinoline derivatives
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.
ES416383A1 (en) Pharmacejtical preparations
ES451880A1 (en) Toothpaste compostion
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
HU174981B (en) Process for producing n-bracket-1-allyl-2-pyrrolidylmethyl-bracket closed-2,3-dimethoxy-5-sulfamoyl-benzamide and pharmaceutical compositions containing them as active agents
ES8203349A1 (en) 1,2-Bis(nicotinamido)propane, process for preparing the same and pharmaceutical composition containing the same.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
ES437197A1 (en) 5-Aryltetrazoles
HU174882B (en) Process for producing 1,12-methanooxymethano-indolo-square bracket-2,3-a-square bracket closed-quinolysine derivatives and pharmaceutical compositions containing them as active agents
ES391536A1 (en) Procedure for obtaining antibacterial compositions. (Machine-translation by Google Translate, not legally binding)
HU174754B (en) Process for producing 1,3-dihydro-spiro-bracket-isobenzo-furane-1,4-piperidine-bracket closed derivatives and pharmaceutical compositions containing them as active agents
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
ES331866A1 (en) A procedure to compose therapeutic compositions. (Machine-translation by Google Translate, not legally binding)
GB1375806A (en)